Nanomedicine and Biomaterial Platforms for Photoimmunotherapy

ABSTRACT Photoimmunotherapy, an innovative cancer treatment strategy that integrates photodynamic/photothermal therapy with immune modulation, has achieved significant advances in recent years. Currently, nanomedicine and biomaterial designs in photoimmunotherapy have evolved from simple drug carriers to intelligent systems integrating imaging, phototherapy, immune activation, and even tumor microenvironment modulation functions, capable of effectively eradicating primary tumors while activating systemic antitumor immunity to inhibit distant metastasis and tumor recurrence. In this minireview, we will discuss various nanomedicine and biomaterial platforms, including inorganic nanoparticles, polymeric nanoparticles, and hydrogels, as well as different biologically derived materials, for applications in different types of light‐triggered immunotherapies. Afterward, we will discuss design principles by which these materials enable light‐triggered tumor killing, activate tumor‐specific immune responses, and respond to and modulate the immunosuppressive tumor microenvironment so as to synergistically improve therapeutic outcomes. The potential and challenges associated with using nanomedicine and biomaterial systems for photoimmunotherapy will also be discussed.

Authors

Institutions

Publication Details

Journal
Angewandte Chemie
Published
2026-04-01
DOI
https://doi.org/10.1002/ange.2667102
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nanomedicine and Biomaterial Platforms for Photoimmunotherapy

C.M. Wang, Zhuang Liu
Angewandte Chemie
Nanoplatforms for cancer theranostics
article

Nanomedicine and Biomaterial Platforms for Photoimmunotherapy

C.M. Wang, Zhuang Liu
article en

Abstract

ABSTRACT Photoimmunotherapy, an innovative cancer treatment strategy that integrates photodynamic/photothermal therapy with immune modulation, has achieved significant advances in recent years. Currently, nanomedicine and biomaterial designs in photoimmunotherapy have evolved from simple drug carriers to intelligent systems integrating imaging, phototherapy, immune activation, and even tumor microenvironment modulation functions, capable of effectively eradicating primary tumors while activating systemic antitumor immunity to inhibit distant metastasis and tumor recurrence. In this minireview, we will discuss various nanomedicine and biomaterial platforms, including inorganic nanoparticles, polymeric nanoparticles, and hydrogels, as well as different biologically derived materials, for applications in different types of light‐triggered immunotherapies. Afterward, we will discuss design principles by which these materials enable light‐triggered tumor killing, activate tumor‐specific immune responses, and respond to and modulate the immunosuppressive tumor microenvironment so as to synergistically improve therapeutic outcomes. The potential and challenges associated with using nanomedicine and biomaterial systems for photoimmunotherapy will also be discussed.

Angewandte ChemieVol. 138(19)
Soochow University (CN), Ascepion Pharmaceuticals (China) (CN)
National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Fundo para o Desenvolvimento das Ciências e da Tecnologia, Collaborative Innovation Center of Suzhou Nano Science and Technology
Good health and well-being
Openalex Percentile: Top 37%
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.